Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

MCKESSON CORPORATION

(MCK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

McKesson : Changes Business-Unit Structure

share with twitter share with LinkedIn share with facebook
07/01/2020 | 04:43pm EDT

By Micah Maidenberg

 

McKesson Corp. said Wednesday it has revamped its business units, a move the company said will help it operate more efficiently

The distributor of pharmaceuticals and other health products will start using four reportable segments:

U.S. Pharmaceutical and Specialty Solutions segment will focus on wholesale drug distribution and technology products for retail pharmacies, health systems and other clients, the company said, as well as U.S. oncology offerings.

Prescription Technology Solutions encompasses the company's work with biopharma and life sciences partners and patients.

International covers McKesson Canada's and McKesson Europe's drug distribution services, specialty pharmacy, retail and infusion care services in those markets.

The fourth segment, Medical-Surgical Solutions, is unaffected by the realignment, the company said.

"McKesson expects to transition to financial reporting under the new four-segment structure for periods commencing after the first quarter of fiscal 2021," the company added.

 

Write to Micah Maidenberg at micah.maidenberg@wsj.com

 

share with twitter share with LinkedIn share with facebook
Latest news on MCKESSON CORPORATION
10:06aMCKESSON : The US Oncology Network Names Vivek Kavadi, MD, Chief Radiation Oncol..
PU
08/03MCKESSON : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
08/03Nasdaq hits record high close as traders eye M&A and stimulus
RE
08/03Microsoft, Apple lift Wall St as investors await stimulus
RE
08/03Earnings, Microsoft boost Wall St as investors await stimulus
RE
08/03Microsoft, Apple lift Wall Street as investors await stimulus
RE
08/03Earnings, Microsoft set to boost Wall St as investors await stimulus
RE
08/03MCKESSON : Lifts FY21 Adjusted Profit Forecast As Volumes Look Better
DJ
08/03MCKESSON : 1Q Sales, Adjusted Profit Ahead Of Expectations, But Pandemic Weighs ..
DJ
08/03MCKESSON CORP : Results of Operations and Financial Condition (form 8-K)
AQ
More news
Financials (USD)
Sales 2021 239 B - -
Net income 2021 2 066 M - -
Net Debt 2021 1 651 M - -
P/E ratio 2021 12,3x
Yield 2021 1,10%
Capitalization 25 467 M 25 467 M -
EV / Sales 2021 0,11x
EV / Sales 2022 0,11x
Nbr of Employees 70 000
Free-Float 59,0%
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 180,88 $
Last Close Price 157,02 $
Spread / Highest target 33,7%
Spread / Average Target 15,2%
Spread / Lowest Target -6,38%
EPS Revisions
Managers
NameTitle
Brian Scott Tyler Chief Executive Officer & Director
Edward A. Mueller Chairman
Britt Vitalone Chief Financial Officer & Executive Vice President
Nancy Flores EVP, Chief Technology & Information Officer
M. Christine Jacobs Independent Director
Sector and Competitors